https://investor.ironwoodpharma.com/press-releases/press-release-details/2011/Ironwood-Announces-Linaclotide-European-Regulatory-Submission-for-the-Treatment-of-Irritable-Bowel-Syndrome-with-Constipation/default.aspx
Ironwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients.
- September 29, 2011